Personal information

Italy

Activities

Employment (1)

Centro di Riferimento Oncologico di Aviano (CRO) IRCCS: Aviano, Pordenone, IT

2006 to present | Resident Researcher (Experimental and Clinical Pharmacology Unit)
Employment
Source: Self-asserted source
Erika Cecchin

Works (50 of 113)

Items per page:
Page 1 of 3

Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?

British Journal of Clinical Pharmacology
2025-02 | Journal article
Contributors: Elena Peruzzi; Rossana Roncato; Elena De Mattia; Alessia Bignucolo; Jesse J. Swen; Henk‐Jan Guchelaar; Giuseppe Toffoli; Erika Cecchin
Source: check_circle
Crossref

Pharmacogenetic Information on Drug Labels of the Italian Agency of Medicines (AIFA): Actionability and Comparison Across Other Regulatory Agencies

Clinical and Translational Science
2025-02 | Journal article
Contributors: Antonino Moschella; Soumaya Mourou; Samantha Perfler; Enrico Zoroddu; Daiana Bezzini; Dorian Soru; Claudia Trignano; Monica Miozzo; Alessio Squassina; Erika Cecchin et al.
Source: check_circle
Crossref

Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring

International Journal of Molecular Sciences
2024-09 | Journal article | Author
Contributors: Eleonora Cecchin; Marco Orleni; Sara Gagno; Marcella Montico; Elena Peruzzi; ROSSANA RONCATO; Lorenzo Gerratana; Serena Corsetti; Fabio Puglisi; Giuseppe Toffoli et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Somatic pharmacogenomics in the treatment prognosis of locally advanced rectal cancer patients: a narrative review of the literature

Expert Review of Clinical Pharmacology
2024-08-02 | Journal article
Contributors: Noemi Milan; Federico Navarria; Erika Cecchin; Elena De Mattia
Source: check_circle
Crossref

Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy

Cell Death & Disease
2024-01-18 | Journal article
Contributors: Caterina Vianello; Veronica Cocetta; Daniela Catanzaro; Gerald W Dorn, II; Angelo De Milito; Flavio Rizzolio; Vincenzo Canzonieri; Erika Cecchin; Rossana Roncato; Giuseppe Toffoli et al.
Source: check_circle
Crossref

Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation

Pharmacogenomics
2023-12 | Journal article
Contributors: Sara Gagno; Chiara Dalle Fratte; Bianca Posocco; Angela Buonadonna; Arianna Fumagalli; Michela Guardascione; Giuseppe Toffoli; Erika Cecchin
Source: check_circle
Crossref

Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab

Clinical Pharmacology & Therapeutics
2023-09 | Journal article
Contributors: Maurizio Polano; Luca Bedon; Michele Dal Bo; Roberto Sorio; Michele Bartoletti; Elena De Mattia; Erika Cecchin; Carmela Pisano; Domenica Lorusso; Andrea Alberto Lissoni et al.
Source: check_circle
Crossref

Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy

Cell Death & Disease
2023-08-29 | Journal article
Contributors: Caterina Vianello; Veronica Cocetta; Daniela Catanzaro; Gerald W Dorn, II; Angelo De Milito; Flavio Rizzolio; Vincenzo Canzonieri; Erika Cecchin; Rossana Roncato; Giuseppe Toffoli et al.
Source: check_circle
Crossref

The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure

DARU Journal of Pharmaceutical Sciences
2023-06-15 | Journal article
Contributors: Sara Gagno; Angela Buonadonna; Chiara Dalle Fratte; Michela Guardascione; Martina Zanchetta; Bianca Posocco; Marco Orleni; Giovanni Canil; Rossana Roncato; Erika Cecchin et al.
Source: check_circle
Crossref

Impact of <i>ABCG2</i> and <i>ABCB1</i> Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis

International Journal of Molecular Sciences
2023-02 | Journal article | Author
Contributors: Chiara Dalle Fratte; Jerry Polesel; Sara Gagno; Bianca Posocco; Elena De Mattia; ROSSANA RONCATO; Marco Orleni; Fabio Puglisi; Michela Guardascione; Angela Buonadonna et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Predictive and Prognostic Value of Oncogene Mutations and Microsatellite Instability in Locally-Advanced Rectal Cancer Treated with Neoadjuvant Radiation-Based Therapy: A Systematic Review and Meta-Analysis

Cancers
2023-02-25 | Journal article
Contributors: Elena De Mattia; Jerry Polesel; Silvia Mezzalira; Elisa Palazzari; Sara Pollesel; Giuseppe Toffoli; Erika Cecchin
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer

Pharmaceutics
2022-12-07 | Journal article
Contributors: Lucia Scarabel; Jerry Polesel; Elena De Mattia; Angela Buonadonna; Mario Rosario D'Andrea; Erika Cecchin; Giuseppe Toffoli
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Pharmacogenetics Role of Genetic Variants in Immune-Related Factors: A Systematic Review Focusing on mCRC

Pharmaceutics
2022-11-15 | Journal article
Contributors: Lucia Scarabel; Alessia Bignucolo; Giuseppe Toffoli; Erika Cecchin; Elena De Mattia
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers

Expert Review of Clinical Pharmacology
2022-06-03 | Journal article
Contributors: Alessia Bignucolo; Lucia Scarabel; Giuseppe Toffoli; Erika Cecchin; Elena De Mattia
Source: check_circle
Crossref

Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy

Cell Death & Disease
2022-05-09 | Journal article
Contributors: Caterina Vianello; Veronica Cocetta; Daniela Catanzaro; Gerald W Dorn, II; Angelo De Milito; Flavio Rizzolio; Vincenzo Canzonieri; Erika Cecchin; Rossana Roncato; Giuseppe Toffoli et al.
Source: check_circle
Crossref

Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy

Cell Death & Disease
2022-04-22 | Journal article
Contributors: Caterina Vianello; Veronica Cocetta; Daniela Catanzaro; Gerald W Dorn, II; Angelo De Milito; Flavio Rizzolio; Vincenzo Canzonieri; Erika Cecchin; Rossana Roncato; Giuseppe Toffoli et al.
Source: check_circle
Crossref

Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis

Vaccines
2021-07-27 | Journal article
Contributors: Alessia Bignucolo; Lucia Scarabel; Silvia Mezzalira; Jerry Polesel; Erika Cecchin; Giuseppe Toffoli
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm

Cancers
2021-04 | Journal article | Author
Contributors: Elena De Mattia; Jerry Polesel; ROSSANA RONCATO; Adrien Labriet; Alessia Bignucolo; Sara Gagno; Angela Buonadonna; Mario D’Andrea; Eric Lévesque; Derek Jonker et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Genetic Variants of the TERT Gene, Telomere Length, and Circulating TERT as Prognostic Markers in Rectal Cancer Patients

Cancers
2020-10-25 | Journal article
Contributors: Enrica Rampazzo; Erika Cecchin; Paola Del Bianco; Chiara Menin; Gaya Spolverato; Silvia Giunco; Sara Lonardi; Sandro Malacrida; Antonino De Paoli; Giuseppe Toffoli et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions

International journal of molecular sciences
2020-09 | Journal article
Contributors: Roncato R; Angelini J; Pani A; Cecchin E; Sartore-Bianchi A; Siena S; De Mattia E; Scaglione F; Toffoli G
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

Pharmacogenetic Score Predicts Overall Survival, Progression-Free Survival and Platinum Sensitivity in Ovarian Cancer

Pharmacogenomics
2020-09 | Journal article
Contributors: Sara Gagno; Michele Bartoletti; Chiara Romualdi; Elena Poletto; Simona Scalone; Roberto Sorio; Martina Zanchetta; Elena De Mattia; Rossana Roncato; Erika Cecchin et al.
Source: check_circle
Crossref

CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions

International Journal of Molecular Sciences
2020-09-01 | Journal article
Contributors: Rossana Roncato; Jacopo Angelini; Arianna Pani; Erika Cecchin; Andrea Sartore-Bianchi; Salvatore Siena; Elena De Mattia; Francesco Scaglione; Giuseppe Toffoli
Source: check_circle
Crossref

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.

Pharmacogenetics and genomics
2020-08 | Journal article
Contributors: van der Wouden CH; Böhringer S; Cecchin E; Cheung KC; Dávila-Fajardo CL; Deneer VHM; Dolžan V; Ingelman-Sundberg M; Jönsson S; Karlsson MO et al.
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway.

Cancer chemotherapy and pharmacology
2020-08 | Journal article
Contributors: Lucafò M; Sicari D; Chicco A; Curci D; Bellazzo A; Di Silvestre A; Pegolo C; Autry R; Cecchin E; De Iudicibus S et al.
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy.

Frontiers in pharmacology
2020-06 | Journal article
Contributors: De Mattia E; Roncato R; Palazzari E; Toffoli G; Cecchin E
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

Pharmacogenomics and Personalized Medicine

Genes
2020-06-22 | Journal article
Contributors: Erika Cecchin; Gabriele Stocco
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
2020-05 | Journal article
Contributors: Cecchin E; De Mattia E; Dreussi E; Montico M; Palazzari E; Navarria F; Bergamo F; Belluco C; Quartuccio L; De Vita S et al.
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
2020-04 | Journal article
Contributors: Dal Bo M; De Mattia E; Baboci L; Mezzalira S; Cecchin E; Assaraf YG; Toffoli G
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients.

The AAPS journal
2020-03 | Journal article
Contributors: Karas S; Etheridge AS; Tsakalozou E; Ramírez J; Cecchin E; van Schaik RHN; Toffoli G; Ratain MJ; Mathijssen RHJ; Forrest A et al.
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib.

Frontiers in pharmacology
2020-02 | Journal article
Contributors: Dalle Fratte C; Guardascione M; De Mattia E; Borsatti E; Boschetto R; Farruggio A; Canzonieri V; Romanato L; Borsatti R; Gagno S et al.
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Clinical Breast Cancer
2019 | Journal article
EID:

2-s2.0-85058825217

Contributors: Gagno, S.; D'Andrea, M.R.; Mansutti, M.; Zanusso, C.; Puglisi, F.; Dreussi, E.; Montico, M.; Biason, P.; Cecchin, E.; Iacono, D. et al.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier

Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants

Genes
2019 | Journal article
EID:

2-s2.0-85068383024

Contributors: Lucafò, M.; Stocco, G.; Martelossi, S.; Favretto, D.; Franca, R.; Malusà, N.; Lora, A.; Bramuzzo, M.; Naviglio, S.; Cecchin, E. et al.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier
grade
Preferred source (of 2)‎

Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts

Clinical Pharmacology and Therapeutics
2019 | Journal article
EID:

2-s2.0-85068184014

Contributors: Just, K.S.; Turner, R.M.; Dolžan, V.; Cecchin, E.; Swen, J.J.; Gurwitz, D.; Stingl, J.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier

Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity

American Journal of Human Genetics
2019 | Journal article
EID:

2-s2.0-85066429356

Contributors: Fragoulakis, V.; Roncato, R.; Fratte, C.D.; Ecca, F.; Bartsakoulia, M.; Innocenti, F.; Toffoli, G.; Cecchin, E.; Patrinos, G.P.; Mitropoulou, C.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier

FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy

Genes
2019 | Journal article
EID:

2-s2.0-85068370668

Contributors: Roncato, R.; Cin, L.D.; Mezzalira, S.; Comello, F.; De Mattia, E.; Bignucolo, A.; Giollo, L.; D’Errico, S.; Gulotta, A.; Emili, L. et al.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier

Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients

Scientific reports
2019 | Journal article
EID:

2-s2.0-85072046555

Contributors: Labriet, A.; Lévesque, É.; Cecchin, E.; De Mattia, E.; Villeneuve, L.; Rouleau, M.; Jonker, D.; Couture, F.; Simonyan, D.; Allain, E.P. et al.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier

Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma

World Journal of Gastroenterology
2019 | Journal article
EID:

2-s2.0-85071281402

Contributors: De Mattia, E.; Cecchin, E.; Guardascione, M.; Foltran, L.; Di Raimo, T.; Angelini, F.; D'Andrea, M.; Toffoli, G.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier

RPL28 PROMOTER POLYMORPHISM RS4806668 IS ASSOCIATED WITH REDUCED SURVIVAL IN FOLFIRI-TREATED METASTATIC COLORECTAL CANCER PATIENTS

Drug Metabolism and Pharmacokinetics
2019 | Journal article
Contributors: Labriet, Adrien; Levesque, Eric; Cecchin, Erika; De Mattia, Elena; Jonker, Derek; Couture, Felix; Simonyan, David; Buonadonna, Angela; D'Andrea, Mario; Villeneuve, Lyne et al.
Source: check_circle
Web of Science Researcher Profile Sync

A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.

Gynecologic oncology
2019-11 | Journal article
Contributors: Gagno S; Poletto E; Bartoletti M; Quartuccio L; Romualdi C; Garziera M; Scalone S; Sorio R; Dreussi E; Zanusso C et al.
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

Combination of germline variations associated with survival of folinic acid, fluorouracil and irinotecan-treated metastatic colorectal cancer patients.

Pharmacogenomics
2019-11 | Journal article
Contributors: Labriet A; Lévesque É; De Mattia E; Cecchin E; Jonker D; Couture F; Simonyan D; Buonadonna A; D'Andrea M; Villeneuve L et al.
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI.

Frontiers in oncology
2019-11 | Journal article
Contributors: De Mattia E; Polesel J; Roncato R; Labriet A; Bignucolo A; Dreussi E; Romanato L; Guardascione M; Buonadonna A; D'Andrea M et al.
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy Outcomes

International Journal of Molecular Sciences
2019-11-05 | Journal article
Contributors: Silvia Mezzalira; Elena De Mattia; Michela Guardascione; Chiara Dalle Fratte; Erika Cecchin; Giuseppe Toffoli
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)

Cells
2019-10-01 | Journal article
Contributors: Marica Garziera; Erika Cecchin; Giorgio Giorda; Roberto Sorio; Simona Scalone; Elena De Mattia; Rossana Roncato; Sara Gagno; Elena Poletto; Loredana Romanato et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study

Genes
2019-09-05 | Journal article
Contributors: Matteo Dugo; Andrea Devecchi; Loris De Cecco; Erika Cecchin; Delia Mezzanzanica; Marialuisa Sensi; Marina Bagnoli
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Genetic markers of the host to predict the efficacy of colorectal cancer targeted therapy.

Current medicinal chemistry
2019-07 | Journal article
Contributors: De Mattia E; Bignucolo A; Toffoli G; Cecchin E
Source: Self-asserted source
Erika Cecchin via Europe PubMed Central

New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach

Cells
2019-06 | Journal article | Author
Contributors: Marica Garziera; ROSSANA RONCATO; Marcella Montico; Elena De Mattia; Sara Gagno; Elena Poletto; Simona Scalone; Vincenzo Canzonieri; Giorgio Giorda; Roberto Sorio et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

rs4143815-<i>PDL1</i>, a New Potential Immunogenetic Biomarker of Biochemical Recurrence in Locally Advanced Prostate Cancer after Radiotherapy

International Journal of Molecular Sciences
2019-04 | Journal article | Author
Contributors: Chiara Zanusso; Eva Dreussi; Roberto Bortolus; Chiara Romualdi; Sara Gagno; Elena De Mattia; Loredana Romanato; Franca Sartor; Luca Quartuccio; Erika Cecchin et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy

Frontiers in Pharmacology
2018 | Journal article
EID:

2-s2.0-85055330525

Contributors: De Mattia, E.; Dreussi, E.; Montico, M.; Gagno, S.; Zanusso, C.; Quartuccio, L.; De Vita, S.; Guardascione, M.; Buonadonna, A.; D'Andrea, M. et al.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier

Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-related gastrointestinal toxicity in metastatic colorectal cancer patients

Frontiers in Pharmacology
2018 | Journal article
EID:

2-s2.0-85045383727

Contributors: De Mattia, E.; Cecchin, E.; Montico, M.; Labriet, A.; Guillemette, C.; Dreussi, E.; Roncato, R.; Bignucolo, A.; Buonadonna, A.; D'Andrea, M. et al.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier

Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation

Drug Resistance Updates
2018 | Journal article
EID:

2-s2.0-85049842575

Contributors: Cecchin, E.; De Mattia, E.; Ecca, F.; Toffoli, G.
Source: Self-asserted source
Erika Cecchin via Scopus - Elsevier
Items per page:
Page 1 of 3

Peer review (50 reviews for 15 publications/grants)

Review activity for British journal of clinical pharmacology (1)
Review activity for British journal of pharmacology. (3)
Review activity for Cancers. (1)
Review activity for Clinical and translational science. (1)
Review activity for Clinical pharmacology & therapeutics. (6)
Review activity for European journal of human genetics (2)
Review activity for Expert opinion on drug metabolism and toxicology (1)
Review activity for Expert review of clinical pharmacology (2)
Review activity for Human genetics. (1)
Review activity for Human genomics (1)
Review activity for Journal of chemotherapy (4)
Review activity for Journal of clinical oncology : (3)
Review activity for Pharmacogenetics and genomics. (1)
Review activity for Progress in neuro-psychopharmacology & biological psychiatry. (2)
Review activity for The pharmacogenomics journal. (21)